Cellular adaptation mediated through Nrf2-induced glutamate cysteine ligase up-regulation against oxidative stress caused by iron overload in β-thalassemia/HbE patients

References

• Rees DC, Clegg JB, Weatherall DJ. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia? Blood. 1998;92(6):2141–2146.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Introduction to the problem of hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22(6):551.
   PubMed Web of Science ®Google Scholar
• Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North America. Blood. 2004;104(1):34–39.
   PubMed Web of Science ®Google Scholar
• Aphinives C, Kukongviriyapan U, Jetsrisuparb A, et al. Impaired endothelial function in pediatric hemoglobin E/β-thalassemia patients with iron overload. Southeast Asian J Trop Med Public Health. 2014;45(6):1454–1463.
   PubMed Web of Science ®Google Scholar
• Kukongviriyapan V, Somparn N, Senggunprai L, et al. Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol. 2008;29(1):130–135.
   PubMed Web of Science ®Google Scholar
• Hahalis G, Alexopoulos D, Kremastinos DT, et al. Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med. 2005;118(9):957–967.
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313–322.
   PubMed Web of Science ®Google Scholar
• Seo YJ, Lee JW, Lee EH, et al. Role of glutathione in the adaptive tolerance to H2O2. Free Radic Biol Med. 2004;37(8):1272–1281.
   PubMed Web of Science ®Google Scholar
• Kalpravidh RW, Tangjaidee T, Hatairaktham S, et al. Glutathione redox system in beta -thalassemia/Hb E patients. Sci World J. 2013;2013:543973.
   Google Scholar
• Dickinson DA, Levonen AL, Moellering DR, et al. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic Biol Med. 2004;37(8):1152–1159.
   PubMed Web of Science ®Google Scholar
• Prawan A, Kundu JK, Surh YJ. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal. 2005;7(11–12):1688–1703.
   PubMed Web of Science ®Google Scholar
• Baranano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99(25):16093–16098.
   PubMed Web of Science ®Google Scholar
• Somparn N, Kukongviriyapan U, Tassaneeyakul W, et al. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Eur J Clin Pharmacol. 2007;63(1):43–50.
   PubMed Web of Science ®Google Scholar
• Schiekofer S, Galasso G, Andrassy M, et al. Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes. Diabetes Obes Metab. 2006;8(5):473–482.
   PubMed Web of Science ®Google Scholar
• Li MH, Jang JH, Na HK, et al. Carbon monoxide produced by upregulated heme oxygenase-1 in response to nitrosative stress induces expression of glutamate cysteine ligase in PC12 cells via activation of PI3K-Akt and Nrf2-ARE signaling. J Biol Chem. 2007;282(39):28577–28586.
   Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39(4):199–218.
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
   PubMed Web of Science ®Google Scholar
• Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest. 2002;32(1):55–60.
   PubMedGoogle Scholar
• Trombetta D, Gangemi S, Saija A, et al. Increased protein carbonyl groups in the serum of patients affected by thalassemia major. Ann Hematol. 2006;85(8):520–522.
   PubMed Web of Science ®Google Scholar
• Hirsch RE, Sibmooh N, Fucharoen S, et al. HbE/beta-thalassemia and oxidative stress: the key to pathophysiological mechanisms and novel therapeutics. Antioxid Redox Signal. 2017;26(14):794–813.
   PubMed Web of Science ®Google Scholar
• Prchal J, Srivastava SK, Beutler E. Active transport of GSSG from reconstituted erythrocyte ghosts. Blood. 1975;46(1):111–117.
   PubMed Web of Science ®Google Scholar
• Nur E, Verwijs M, de Waart DR, et al. Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes. Biochim Biophys Acta. 2011;1812(11):1412–1417.
   PubMed Web of Science ®Google Scholar
• Fratta Pasini AM, Ferrari M, Stranieri C, et al. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress. Int J Chronic Obstruct Pulm Dis. 2016;11:1733–1743.
   PubMed Web of Science ®Google Scholar
• Gould NS, Min E, Huang J, et al. Glutathione depletion accelerates cigarette smoke-induced inflammation and airspace enlargement. Toxicol Sci. 2015;147(2):466–474.
   PubMed Web of Science ®Google Scholar
• Schoeneberger H, Belz K, Schenk B, et al. Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death. Oncogene. 2015;34(31):4032–4043.
   PubMed Web of Science ®Google Scholar
• Ning B, Bai M, Shen W. Reduced glutathione protects human hepatocytes from palmitate-mediated injury by suppressing endoplasmic reticulum stress response. Hepatogastroenterology. 2011;58(110–111):1670–1679.
   PubMedGoogle Scholar
• Zou X, Feng Z, Li Y, et al. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways. J Nutr Biochem. 2012;23(8):994–1006.
   PubMed Web of Science ®Google Scholar
• Seelig GF, Simondsen RP, Meister A. Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. J Biol Chem. 1984;259(15):9345–9347.
   PubMed Web of Science ®Google Scholar
• Yang Y, Dieter MZ, Chen Y, et al. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(−/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem. 2002;277(51):49446–49452.
   PubMed Web of Science ®Google Scholar
• Bresgen N, Eckl PM. Oxidative stress and the homeodynamics of iron metabolism. Biomolecules. 2015;5(2):808–847.
   PubMed Web of Science ®Google Scholar
• Barone E, Mancuso C, Di Domenico F, et al. Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. J Neurochem. 2012;120(1):135–146.
   PubMed Web of Science ®Google Scholar
• Maines MD, Ewing JF, Huang TJ, et al. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J Pharmacol Exp Ther. 2001;296(3):1091–1097.
   PubMed Web of Science ®Google Scholar